Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cholecystolithiasis × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 NET 1 Head & Neck 1 Gynecologic 1 Endocrine 1

Conditions

Neuroendocrine Tumors 345 Carcinoid Tumor 34 Gastro-enteropancreatic neuroendocrine tumor 33 Carcinoma, Neuroendocrine 25 Pancreatic Neoplasms 24 Neoplasms 24 Adenoma, Islet Cell 21 Neoplasm Metastasis 16 Stomach Neoplasms 15 Pheochromocytoma 14 Paraganglioma 14 Gastrointestinal Neoplasms 13 Neuroblastoma 12 Carcinoma, Hepatocellular 12 Thyroid Neoplasms 11 Prostatic Neoplasms 11 Breast Neoplasms 11 Esophageal Neoplasms 10 Colorectal Neoplasms 10 Sarcoma 9 Lung Neoplasms 9 Rectal Neoplasms 8 Gastrointestinal Stromal Tumors 8 Brain Neoplasms 8 Anus Neoplasms 8 Liver Neoplasms 7 Colonic Neoplasms 7 Cholangiocarcinoma 7 Carcinoma, Medullary 7 Carcinoma 7

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04735198 2025-05-20

TNE-IDC-COLE

Hospital Universitari de Bellvitge

Phase NA Recruiting

Neuroendocrine Tumors, Cholecystolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡